The aim of the study was to assess whether different fluorescence grades expressed by GBM cells could be related to a particular histopathological/molecular subtype (methylation of MGMT promoter, mitotic count, proliferation index, and IDH-1/2 gene status), thus, helping to predict the more probable genotype according to detected intra-operative fluorescence. This evidence concerns the gene IDH1 and glioblastoma.